multiplexed sample: Homo sapiens (female, 83 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 6 more samples

multiplexed sample: Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 83 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 83 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 83 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 6 more samples

multiplexed sample: Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 83 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 83 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 6 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 83 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 6 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 83 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 6 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 83 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 6 more samples

multiplexed sample: Homo sapiens (female, 83 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 6 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 83 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 83 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 83 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 83 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 6 more samples

multiplexed sample: Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 83 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 83 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples